GlaxoSmithKline Pharma to enter oncology market, launch adult vax

Quick Summary:

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology market and expanding its preventive healthcare through adult vaccines.

With 30 crore prescriptions annually, GSK aims to innovate and grow its portfolio, highlighting price strategies catering to a broad market range, from general medicines to high-value therapies.

Also, newer therapies are firing up sales," he said.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Rupali Mukherjee

Category: EconomyBusiness

Markets: IndiaChina

Topics: Preventive healthcare Oncology Adult vaccines Biopharma company GSK

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-09 @ 07:48:45 (6 hours ago)

News Timezone: GMT +5:00

News Source URL: timesofindia.indiatimes.com

Language: English

Article Length: 368 words

Reading Time: 3 minutes read

Sentences: 16 lines

Sentence Length: 23 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Times of India

News ID: 22961390

View Article Analysis

About Times of India

Main Topics: EconomyBusiness

Official Website: timesofindia.indiatimes.com

Update Frequency: 16 posts per day

Year Established: 1838

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #28

Publisher Details

Frequently Asked Questions